Thanks for the information... I assumed China was waiting for GMP but nice to here that it will be in partners hands soon. As I’ve stated, the China partnership was a real shocker and a coup for NGIO. China vaccine not performing well against variant in Brazil ... and latest China vaccine is 3 shots each 1 month apart. Great opportunity for NGIO to come in and save the day.

The Pfizer CEO stated, we will move from a pandemic to an endemic next year .... sounds like, in the US, NGIO vaccine will be well positioned either as a booster or possibly to address variants. Pfizer CEO also indicates price for shots will go up next year to $100 - $150. Suggests a lot of revenue for NGIO if the complete vaccine gets final approval...